BSEBoard Meeting6d ago · 12 Aug 2026, 06:08 pm

Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve 1) To consider and approve ....

Vivanza Biosciences Ltd · 530057

✦ AI SummaryResults

Vivanza Biosciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 to consider and approve various business matters, including the Director's Report and Secretarial Audit Report for the Financial Year 2025-26, and to convene the 44th Annual General Meeting.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Vivanza Biosciences Ltd - 530057 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

15151338-d242-442c-9211-aeadfdbd0c7c.pdf

pdf

Download →
View document text
VIVANZA BIOSCIENCES LIMITED Regd. Office: 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054. Phone: 07405699869, email: info@vivanzabiosciences.com, web: www.vivanzabiosciences.com CIN: L24110GJ1982PLC005057 Date: 12.08.2026 Corporate Relationship Department, BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai — 400001 BSE Scrip Code: 530057 ISIN: INE984E01035 Subject: Intimation of Board Meeting under Regulation 29(1)(a) and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 29 and 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 17th day of August, 2026 at the Registered office of the Company to transact the following business: 1) To consider and approve the Director's Report and Secretarial Audit Report along with annexure for the Financial Year 2025-26; 2) To consider and approve the convening of the 44th Annual General Meeting (AGM) of the Members of the Company and to approve the draft Notice of the 44th Annual General Meeting (AGM) of the Company; 3) To appoint Mr. Chintan K. Patel, Practicing Company Secretary (Mem No: A31987, COP: 11959) as Scrutinizer for the e-voting and poll process of the 44th AGM; 4) Fixing of September 04, 2026 as the "Cut-Off Date" to ascertain the names of Members who will be entitled to attend and vote in E-Voting at the 44th Annual General Meeting of the Company. 5) To consider and approve the proposal for adoption of the Memorandum of Association and Articles of Association of the Company in conformity with the provisions of the Companies Act, 2013, and to recommend the same for approval of the Members at the ensuing Annual General Meeting. 6) To consider and approve the proposal for obtaining approval of the Members for the proposed borrowings under Section 180(1)(c) of the Companies Act, 2013. 7) To consider and approve the proposal for obtaining approval of the Members for the proposed transaction(s) under Section 185 of the Companies Act, 2013, as applicable. 8) To consider and approve the proposal for obtaining approval of the Members under Section 186 of the Companies Act, 2013 for the proposed investments, loans, guarantees and/or securities. 9) Any other business as Board deems fit to discuss, with the permission of the Chair. VIVANZA BIOSCIENCES LIMITED Regd. Office: 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054. Phone: 07405699869, email: info@vivanzabiosciences.com, web: www.vivanzabiosciences.com CIN: L24110GJ1982PLC005057 We request you to take the same on record. Thanking You. For, Vivanza Biosciences Limited Jayendra Mehta Managing Director DIN: 08210602